Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ABOS - Acumen Pharmaceuticals Inc. (ABOS) CEO Daniel O'Connell on Q1 2022 Results - Earnings Call Transcript

ABOS - Acumen Pharmaceuticals Inc. (ABOS) CEO Daniel O'Connell on Q1 2022 Results - Earnings Call Transcript

Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2022 Earnings Conference Call May 16, 2022, 04:30 PM ET Company Participants John Woolford - IR, Westwicke Daniel O'Connell - President & CEO Eric Siemers - Chief Medical Officer Matt Zuga - CFO & Chief Business Officer Conference Call Participants Presentation Operator Operator Thank you for standing by, and welcome to the Acumen Pharmaceuticals, First Quarter 2022 Update Call. At this time, all participants are in a listen-only mode. There'll be a brief overview followed by a question-and-answer session. [Operator Instructions] Today's call is being recorded. And I would now like to turn the call over to John Woolford from Westwicke. Please go ahead. John Woolford Thank you, operator good afternoon. Thank you for joining us today to review Acumen’s first quarter 2022 update on operational progress and financial results. Before we start, we encourage you to read the operational and financial results press release

For further details see:

Acumen Pharmaceuticals, Inc. (ABOS) CEO Daniel O'Connell on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Acumen Pharmaceuticals Inc.
Stock Symbol: ABOS
Market: NASDAQ
Website: acumenpharm.com
Menu
ABOS ABOS Quote ABOS Short ABOS News ABOS Articles ABOS Message Board
Get ABOS Alerts

News, Short Squeeze, Breakout and More Instantly...